Published in Am J Public Health on August 01, 1994
Effect of trihalomethane exposure on fetal development. Occup Environ Med (2003) 1.20
The association of drinking water source and chlorination by-products with cancer incidence among postmenopausal women in Iowa: a prospective cohort study. Am J Public Health (1997) 1.15
Drinking water and cancer. Environ Health Perspect (1995) 1.09
Toxicity of the Yangtze River source of drinking water on reproductive system of male mice (Mus musculus). Ecotoxicology (2009) 0.99
Case control study of the geographic variability of exposure to disinfectant byproducts and risk for rectal cancer. Int J Health Geogr (2007) 0.88
Water chlorination, mutagenicity, and cancer epidemiology. Am J Public Health (1994) 0.87
3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) and mutagenic activity in Massachusetts drinking water. Environ Health Perspect (2002) 0.81
Bromochloromethane, a Methane Analogue, Affects the Microbiota and Metabolic Profiles of the Rat Gastrointestinal Tract. Appl Environ Microbiol (2015) 0.79
Assessing exposure to carcinogens in drinking water. Am J Public Health (1995) 0.75
Investigation of potential genotoxic activity using the SOS Chromotest for real paracetamol wastewater and the wastewater treated by the Fenton process. J Environ Health Sci Eng (2015) 0.75
Revised methods for the Salmonella mutagenicity test. Mutat Res (1983) 11.60
Chlorination, chlorination by-products, and cancer: a meta-analysis. Am J Public Health (1992) 2.86
Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst (1987) 1.77
Estimating Rn-induced lung cancer in the United States. Health Phys (1989) 1.61
Cancers of affluence: positive social class gradient and rising incidence trend in some cancer forms. Soc Sci Med (1987) 1.41
Nonvolatile mutagens in drinking water: production by chlorination and destruction by sulfite. Science (1980) 1.17
Drinking water mutagenicity in past exposure assessment of the studies on drinking water and cancer: application and evaluation in Finland. Environ Res (1994) 1.08
Socioeconomic status and education as risk determinants of gastrointestinal cancer. Prev Med (1986) 1.03
Oxidative metabolism of aflatoxin B1 by rat liver microsomes in vitro and its effect on lipid peroxidation. Res Commun Chem Pathol Pharmacol (1974) 1.01
Occupation and smoking as risk determinants of lung cancer. Int J Epidemiol (1983) 1.00
Chlorination of drinking water and cancer incidence in Norway. Int J Epidemiol (1992) 0.98
High levels of mutagenic activity in chlorinated drinking water in Finland. Mutat Res (1986) 0.98
Cytogenetic effects of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in rat peripheral lymphocytes in vitro and in vivo. Mutat Res (1993) 0.95
Social class and changes in health-related habits in Finland in 1973-1983. Scand J Soc Med (1986) 0.87
Pharmacokinetics in rat of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a drinking water mutagen, after a single dose. Pharmacol Toxicol (1992) 0.81
Impact of bleached kraft mill effluents on drinking water quality. Sci Total Environ (1988) 0.81
Binding of the strong bacterial mutagen, 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) to bovine serum albumin. Toxicol Lett (1991) 0.80
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (2001) 6.23
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol (1994) 4.89
Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol (2008) 4.78
What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer (2009) 4.31
Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A (2001) 3.31
Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics (1982) 3.18
Coeliac disease--associated disorders and survival. Gut (1994) 3.13
A computer program package for relative survival analysis. Comput Programs Biomed (1985) 3.10
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis (1978) 3.08
Aggressiveness of screen-detected breast cancers. Lancet (1995) 3.07
Secular trend in the occurrence of asthma among children and young adults: critical appraisal of repeated cross sectional surveys. BMJ (1997) 2.97
Assessment of exposure to environmental tobacco smoke. Eur Respir J (1997) 2.85
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
Relation between ambient air pollution and low birth weight in the Northeastern United States. Environ Health Perspect (2001) 2.44
Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ (1997) 2.41
Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat. J Natl Cancer Inst (1997) 2.38
Social class as a prognostic factor in breast cancer survival. Cancer (1990) 2.37
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Risk of cancer in Finnish children living close to power lines. BMJ (1993) 2.29
Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology (2000) 2.25
Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry (2001) 2.23
Exposure to pets and atopy-related diseases in the first 4 years of life. Allergy (2001) 2.11
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev (2005) 2.08
From cross-tabulations to multipurpose exposure information systems: a new job-exposure matrix. Am J Ind Med (1998) 2.07
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07
Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06
Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92. BMJ (1994) 2.04
Progression of asbestosis predicts lung cancer. Chest (1998) 2.02
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93
Multiple cancer--an epidemiologic exercise in Finland. J Natl Cancer Inst (1985) 1.87
Work-related cancer in the Nordic countries. Scand J Work Environ Health (1999) 1.84
Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect (1999) 1.84
Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol (1999) 1.84
Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol (1995) 1.84
Cancer registration: principles and methods. Analysis of survival. IARC Sci Publ (1991) 1.84
Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol (1999) 1.83
Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med (1999) 1.82
Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer (2003) 1.79
The effects of diazepam or diphenhydramine on healthy human subjects. Psychopharmacologia (1971) 1.77
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Leukemia following chemotherapy for ovarian cancer. N Engl J Med (1990) 1.76
In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J (1997) 1.75
Form of day care and respiratory infections among Finnish children. Am J Public Health (1995) 1.73
Incidence of childhood cancer in Finland. J Natl Cancer Inst (1975) 1.73
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol (2000) 1.71
Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect (2007) 1.69
Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer (2004) 1.68
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64
The effect of air humidification on symptoms and perception of indoor air quality in office workers: a six-period cross-over trial. Arch Environ Health (1992) 1.63
Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med (1999) 1.63
Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63
Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet (2005) 1.61
Non-carcinogenic effects of TCDD in animals. Food Addit Contam (2000) 1.60
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer (2000) 1.59
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol (1993) 1.58
Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol (1996) 1.58
Outcome-based equity in the treatment of colon cancer patients in Finland. Int J Technol Assess Health Care (1989) 1.57
Dioxins, polychlorinated biphenyls, methyl mercury and omega-3 polyunsaturated fatty acids as biomarkers of fish consumption. Eur J Clin Nutr (2010) 1.57
Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med (1995) 1.56
Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer (1999) 1.56
Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol (1997) 1.56
Possible explanations for social class differences in cancer patient survival. IARC Sci Publ (1997) 1.55
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: nationwide cohort study. BMJ (1996) 1.55
Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol Rev (1994) 1.55
Weight gain during the first year of life in relation to maternal smoking and breast feeding in Norway. J Epidemiol Community Health (1997) 1.55
Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54
Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect". Am J Obstet Gynecol (1994) 1.53
Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer (1995) 1.52
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia (2005) 1.52
Cancer in the offspring of fathers in hydrocarbon-related occupations. Br J Prev Soc Med (1976) 1.51
Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987. Eur J Cancer (1996) 1.50
Selective screening: theory and practice based on high-risk groups of cervical cancer. J Epidemiol Community Health (1979) 1.48
Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol (2001) 1.46
Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite and N-nitroso compounds: a follow-up study. Int J Cancer (1999) 1.46
Office equipment and supplies: a modern occupational health concern? Am J Epidemiol (1999) 1.46
Testicular cancer in Europe and the USA: survival still rising among older patients. Ann Oncol (2012) 1.45
Glycophorin A biodosimetry in Chernobyl cleanup workers from the Baltic countries. BMJ (1996) 1.45
Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol (1988) 1.45
Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen (1999) 1.45
Assignment of an Usher syndrome type III (USH3) gene to chromosome 3q. Hum Mol Genet (1995) 1.42